What is the ROE (Return on Equity) of Genedrive this year?
The ROE of Genedrive this year is -2.52 undefined.
Genedrive ROE 2025
Genedrive ROE
-2.52
Ticker
GDR.L
ISIN
GB00B1VKB244
WKN
A0ML2T
In 2025, Genedrive's return on equity (ROE) was -2.52, a 202.85% increase from the -0.83 ROE in the previous year.
Genedrive Aktienanalyse
What does Genedrive do?
Genedrive PLC is a biomedical company based in Manchester, United Kingdom, specializing in the development of innovative diagnostic tests for infectious diseases and cancer. The company was founded in 2007 under the name Epistem Limited and went public in 2013. The business model of Genedrive involves developing and distributing innovative molecular diagnostic tests for diseases worldwide. The company's main goal is to change the way infectious diseases and cancer are diagnosed and treated by offering rapid, accurate, and cost-effective tests. The company has two main divisions: Genprobe and Instruments. Under Genprobe, various in vitro diagnostic tests for infectious diseases and diseases of the human immune system, including tuberculosis, hepatitis C, hepatitis B, HIV, and others, are offered. Under Instruments, Genedrive offers PCR instruments used for analyzing samples for DNA and RNA sequences. Some of Genedrive's key products include: - Genedrive HCV-ID Testkit: A test kit for identifying and quantifying hepatitis C viruses (HCV) in human blood samples. The test provides results within 90 minutes and has high accuracy. - Genedrive MT-RNR1 Testkit: A test kit for the rapid diagnosis of tuberculosis (TB), one of the most common infectious diseases worldwide. The test utilizes PCR technology and provides results within 90 minutes. - Genedrive Genedrive 96: An instrument for simultaneous analysis of up to 96 PCR samples. The system offers high accuracy and precision in analyzing RNA and DNA sequences. The company collaborates closely with leading research institutions and health organizations worldwide to improve its products and develop new tests. Genedrive has formed partnerships with the British government, the US Department of Defense, and other institutions. In recent years, the company has made significant progress in developing new diagnostic tests for infectious diseases and cancer. For example, Genedrive recently signed an agreement with the Foundation for Innovative New Diagnostics (FIND) to develop a molecular test for the Ebola virus. The company also has a pipeline of projects, including tests for COVID-19 and antibiotic resistance. Despite Genedrive's success, the company remains committed to innovation and research in order to transform the diagnostics industry and improve the health of people worldwide. Genedrive is expected to continue playing an important role in the fight against infectious diseases and cancer in the future. Genedrive ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Genedrive's Return on Equity (ROE)
Genedrive's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Genedrive's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Genedrive's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Genedrive’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Genedrive stock
How has the Return on Equity (ROE) of Genedrive developed compared to the previous year?
The ROE of Genedrive has increased by 202.85% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Genedrive?
A high ROE indicates that Genedrive generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Genedrive?
A low ROE can indicate that Genedrive is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Genedrive affect the company?
A change in ROE (Return on Equity) of Genedrive can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Genedrive?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Genedrive?
Some factors that can influence Genedrive's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Genedrive pay?
Over the past 12 months, Genedrive paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genedrive is expected to pay a dividend of 0 GBP.
What is the dividend yield of Genedrive?
The current dividend yield of Genedrive is .
When does Genedrive pay dividends?
Genedrive pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genedrive?
Genedrive paid dividends every year for the past 0 years.
What is the dividend of Genedrive?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genedrive located?
Genedrive is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genedrive kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genedrive from 1/15/2025 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 1/15/2025.
When did Genedrive pay the last dividend?
The last dividend was paid out on 1/15/2025.
What was the dividend of Genedrive in the year 2024?
In the year 2024, Genedrive distributed 0 GBP as dividends.
In which currency does Genedrive pay out the dividend?
The dividends of Genedrive are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Genedrive
Our stock analysis for Genedrive Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genedrive Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
